Saturday, April 21, 2012

Cellceutix gets FDA meeting on psoriasis drug - Mass High Tech

Cellceutix gets FDA meeting on psoriasis drug Mass High Tech (OTCBB: CTIX) of Beverly aforementioned the US Food and Drug Administration has confirmed a pre-investigational new drug (IND) meeting focused connected a psoriasis treatment for mid-June. The pre-IND message and meeting are related to to Cellceutix's Prurisol (also ... Cellceutix touts possible psoriasis treatment Boston messenger FDA Schedules Meeting With Cellceutix on New disease of the skin Drug MarketWatch (press release) FDA schedules meeting with Cellceutix on psoriasis drug Boston.com all 8 tidings articles » Link To Article

No comments:

Post a Comment